Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Revolution Medicines, Inc. (RVMD) had Cash Flow from Investing Activities of $-1.49B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-644.37M |
|
-- |
|
-- |
|
$505.13M |
|
$-505.13M |
|
$-139.24M |
|
$-644.37M |
|
$-644.37M |
|
$-644.37M |
|
$-644.37M |
|
$-644.37M |
|
$-644.37M |
|
$-505.13M |
|
$-504.96M |
|
210.89M |
|
210.89M |
|
$-3.06 |
|
$-3.06 |
|
| Balance Sheet Financials | |
$4.03B |
|
$34.61M |
|
$294.93M |
|
$4.32B |
|
$354.06M |
|
$1.04B |
|
$1.36B |
|
$1.72B |
|
$2.61B |
|
$2.54B |
|
$2.61B |
|
214.24M |
|
| Cash Flow Statement Financials | |
$-741.48M |
|
|
Cash Flow from Investing Activities |
$-1.49B |
$2.66B |
|
$388.60M |
|
$820.29M |
|
$431.69M |
|
$154.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.38 |
|
-- |
|
-- |
|
0.28 |
|
0.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-745.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.72% |
|
-25.41% |
|
-14.90% |
|
-17.69% |
|
$12.16 |
|
$-3.53 |
|
$-3.52 |
|